chr11-77211141-G-C

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The NM_000260.4(MYO7A):​c.6052-11G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00353 in 1,561,020 control chromosomes in the GnomAD database, including 170 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.017 ( 92 hom., cov: 32)
Exomes 𝑓: 0.0020 ( 78 hom. )

Consequence

MYO7A
NM_000260.4 intron

Scores

2
Splicing: ADA: 0.006439
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 1.13

Publications

2 publications found
Variant links:
Genes affected
MYO7A (HGNC:7606): (myosin VIIA) This gene is a member of the myosin gene family. Myosins are mechanochemical proteins characterized by the presence of a motor domain, an actin-binding domain, a neck domain that interacts with other proteins, and a tail domain that serves as an anchor. This gene encodes an unconventional myosin with a very short tail. Defects in this gene are associated with the mouse shaker-1 phenotype and the human Usher syndrome 1B which are characterized by deafness, reduced vestibular function, and (in human) retinal degeneration. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2008]
MYO7A Gene-Disease associations (from GenCC):
  • nonsyndromic genetic hearing loss
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal recessive nonsyndromic hearing loss 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, G2P
  • Usher syndrome type 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, PanelApp Australia
  • Usher syndrome type 1B
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • autosomal dominant nonsyndromic hearing loss 11
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Usher syndrome type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.33).
BP6
Variant 11-77211141-G-C is Benign according to our data. Variant chr11-77211141-G-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 43316.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0565 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000260.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MYO7A
NM_000260.4
MANE Select
c.6052-11G>C
intron
N/ANP_000251.3
MYO7A
NM_001127180.2
c.5938-11G>C
intron
N/ANP_001120652.1
MYO7A
NM_001369365.1
c.5905-11G>C
intron
N/ANP_001356294.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MYO7A
ENST00000409709.9
TSL:1 MANE Select
c.6052-11G>C
intron
N/AENSP00000386331.3
MYO7A
ENST00000458637.6
TSL:1
c.5938-11G>C
intron
N/AENSP00000392185.2
MYO7A
ENST00000409619.6
TSL:1
c.5905-11G>C
intron
N/AENSP00000386635.2

Frequencies

GnomAD3 genomes
AF:
0.0173
AC:
2636
AN:
152144
Hom.:
90
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0583
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0100
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000426
Gnomad OTH
AF:
0.0167
GnomAD2 exomes
AF:
0.00421
AC:
742
AN:
176362
AF XY:
0.00330
show subpopulations
Gnomad AFR exome
AF:
0.0592
Gnomad AMR exome
AF:
0.00358
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000421
Gnomad OTH exome
AF:
0.00425
GnomAD4 exome
AF:
0.00203
AC:
2865
AN:
1408758
Hom.:
78
Cov.:
31
AF XY:
0.00182
AC XY:
1266
AN XY:
695126
show subpopulations
African (AFR)
AF:
0.0632
AC:
2041
AN:
32294
American (AMR)
AF:
0.00421
AC:
160
AN:
37968
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24932
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36954
South Asian (SAS)
AF:
0.000302
AC:
24
AN:
79562
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50006
Middle Eastern (MID)
AF:
0.00811
AC:
46
AN:
5672
European-Non Finnish (NFE)
AF:
0.000259
AC:
281
AN:
1082964
Other (OTH)
AF:
0.00536
AC:
313
AN:
58406
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
131
263
394
526
657
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
72
144
216
288
360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0174
AC:
2650
AN:
152262
Hom.:
92
Cov.:
32
AF XY:
0.0169
AC XY:
1261
AN XY:
74448
show subpopulations
African (AFR)
AF:
0.0585
AC:
2429
AN:
41554
American (AMR)
AF:
0.0100
AC:
153
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000426
AC:
29
AN:
68010
Other (OTH)
AF:
0.0166
AC:
35
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
121
241
362
482
603
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00893
Hom.:
6
Bravo
AF:
0.0196

ClinVar

ClinVar submissions as Germline
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
1
Autosomal dominant nonsyndromic hearing loss 11 (1)
-
-
1
Autosomal recessive nonsyndromic hearing loss 2 (1)
-
-
1
not specified (1)
-
-
1
Usher syndrome type 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.33
CADD
Benign
16
DANN
Benign
0.74
PhyloP100
1.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0064
dbscSNV1_RF
Benign
0.062
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs112564978; hg19: chr11-76922186; API